Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.62B |
| 2 |
Apple
AAPL
|
+$747M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$655M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$427M |
| 5 |
Walt Disney
DIS
|
+$341M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zimmer Biomet
ZBH
|
+$2.63B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 3 |
Yum! Brands
YUM
|
+$734M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$558M |
| 5 |
Visa
V
|
+$398M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.59% |
| 2 | Technology | 8.45% |
| 3 | Healthcare | 7.6% |
| 4 | Consumer Discretionary | 6.86% |
| 5 | Energy | 6.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KBAL
3176
DELISTED
Kimball International
KBAL
| $2.72M | ﹤0.01% |
239,954
+52,430
| +28% | +$553K |
|
3177
Orthofix Medical
OFIX
$496M
| $2.72M | ﹤0.01% |
65,550
+24,513
| +60% | +$961K |
|
3178
Invesco KBW Premium Yield Equity REIT ETF
KBWY
$314M
| $2.71M | ﹤0.01% |
83,098
| – | – |
|
3179
CALL
Plains All American Pipeline
PAA
$17.1B
| $2.71M | ﹤0.01% |
129,200
-352,500
| -73% | -$7.42M |
|
|
RBS.PRS.CL
3180
DELISTED
The Royal Bank Of Scotland Group
RBS.PRS.CL
| $2.71M | ﹤0.01% |
108,793
+86,900
| +397% | +$2.14M |
|
|
FOE
3181
DELISTED
Ferro Corporation
FOE
| $2.71M | ﹤0.01% |
227,967
+103,093
| +83% | +$1.03M |
|
|
DX
3182
Dynex Capital
DX
$3.15B
| $2.71M | ﹤0.01% |
135,628
+21,963
| +19% | +$410K |
|
|
CBM
3183
DELISTED
Cambrex Corporation
CBM
| $2.71M | ﹤0.01% |
61,481
-21,739
| -26% | -$857K |
|
3184
PUT
Universal Health Services
UHS
$10.2B
| $2.69M | ﹤0.01% |
21,600
+4,600
| +27% | +$517K |
|
3185
Brookfield Renewable
BEP
$10.2B
| $2.69M | ﹤0.01% |
168,570
+2,515
| +2% | +$35.6K |
|
3186
WD-40
WDFC
$3.05B
| $2.69M | ﹤0.01% |
24,886
-2,355
| -9% | -$243K |
|
3187
CALL
3D Systems Corp
DDD
$462M
| $2.68M | ﹤0.01% |
173,100
-4,700
| -3% | -$48.5K |
|
3188
Puma Biotechnology
PBYI
$391M
| $2.67M | ﹤0.01% |
91,073
-111,497
| -55% | -$5.04M |
|
3189
CALL
LivaNova
LIVN
$4.53B
| $2.67M | ﹤0.01% |
49,500
-1,800
| -4% | -$100K |
|
|
CS
3190
PUT
DELISTED
Credit Suisse Group
CS
| $2.67M | ﹤0.01% |
188,600
+154,600
| +455% | +$2.46M |
|
3191
PUT
SFL Corp
SFL
$1.65B
| $2.66M | ﹤0.01% |
+191,600
| New | +$2.58M |
|
|
LLTC
3192
CALL
DELISTED
Linear Technology Corp
LLTC
| $2.66M | ﹤0.01% |
59,700
-11,400
| -16% | -$482K |
|
|
3193
PUT
LivaNova
LIVN
$4.53B
| $2.66M | ﹤0.01% |
49,200
| – | – |
|
3194
ProShares Ultra Russell2000
UWM
$240M
| $2.65M | ﹤0.01% |
140,412
+980
| +0.7% | +$16.3K |
|
3195
First Trust Managed Municipal ETF
FMB
$2.05B
| $2.65M | ﹤0.01% |
50,000
| – | – |
|
|
ACOR
3196
PUT
DELISTED
Acorda Therapeutics
ACOR
| $2.65M | ﹤0.01% |
833
-1,584
| -66% | -$6.58M |
|
3197
PUT
Marathon Petroleum
MPC
$89.6B
| $2.64M | ﹤0.01% |
71,000
-23,300
| -25% | -$886K |
|
3198
CALL
Ionis Pharmaceuticals
IONS
$9.06B
| $2.63M | ﹤0.01% |
65,000
-70,000
| -52% | -$2.84M |
|
|
3199
PUT
Ionis Pharmaceuticals
IONS
$9.06B
| $2.63M | ﹤0.01% |
65,000
-110,200
| -63% | -$4.48M |
|
3200
CALL
Avis
CAR
$4.91B
| $2.63M | ﹤0.01% |
96,200
-2,627,300
| -96% | -$71.8M |
|
Similar funds
Goldman Sachs's Q1 2016 Portfolio in Review
As of Q1 2016, Goldman Sachs held 7,717 positions worth $304B, down 4.6% from $319B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Goldman Sachs withdrew a net $11.3B in Q1 2016, closing 656 positions and reducing 3,244 holdings. Its most notable exit was CHUBB CORPORATION, an estimated $383M position sold in full.
By sector, the portfolio is most concentrated in Financials at 8.6% of assets, down from 9.2% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Goldman Sachs opened a new position in Welbilt, Inc. worth $36.5M.
- Goldman Sachs's largest Q1 2016 buy was Welbilt, Inc.: 2,476,061 shares worth $36.5M.
- Goldman Sachs added most to Pfizer in Q1 2016, an estimated $1.62B increase.
- Goldman Sachs's biggest Q1 2016 reduction was Zimmer Biomet, cutting an estimated $2.63B.
- Goldman Sachs fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $383M.
- Goldman Sachs's ten largest holdings make up 15% of its $304B portfolio in Q1 2016.
- Goldman Sachs opened 593 new positions and closed 656 in Q1 2016.
- Goldman Sachs's portfolio value fell 4.6% quarter-over-quarter to $304B.
Based on Goldman Sachs's 13F filing for Q1 2016, filed 13 May 2016.